Correlation Between Medavail Holdings and FSD Pharma

Can any of the company-specific risk be diversified away by investing in both Medavail Holdings and FSD Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medavail Holdings and FSD Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medavail Holdings and FSD Pharma Class, you can compare the effects of market volatilities on Medavail Holdings and FSD Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medavail Holdings with a short position of FSD Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medavail Holdings and FSD Pharma.

Diversification Opportunities for Medavail Holdings and FSD Pharma

0.61

Correlation Coefficient

Medavail Holdings  FSD Pharma

Poor diversification

The 3 months correlation between Medavail and FSD is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Medavail Holdings and FSD Pharma Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FSD Pharma Class and Medavail Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medavail Holdings are associated (or correlated) with FSD Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FSD Pharma Class has no effect on the direction of Medavail Holdings i.e., Medavail Holdings and FSD Pharma go up and down completely randomly.

Pair Corralation between Medavail Holdings and FSD Pharma

Given the investment horizon of 90 days Medavail Holdings is expected to under-perform the FSD Pharma. In addition to that, Medavail Holdings is 6.21 times more volatile than FSD Pharma Class. It trades about -0.23 of its total potential returns per unit of risk. FSD Pharma Class is currently generating about -0.55 per unit of volatility. If you would invest  72.00  in FSD Pharma Class on January 20, 2024 and sell it today you would lose (26.00) from holding FSD Pharma Class or give up 36.11% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	90.48%
Values	Daily Returns

Medavail Holdings  vs.  FSD Pharma Class

Medavail Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medavail Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in May 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

FSD Pharma Class

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days FSD Pharma Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in May 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Medavail Holdings and FSD Pharma

The main advantage of trading using opposite Medavail Holdings and FSD Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medavail Holdings position performs unexpectedly, FSD Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FSD Pharma will offset losses from the drop in FSD Pharma's long position.

The idea behind Medavail Holdings and FSD Pharma Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.